Efficacy of Adalimumab as a long term maintenance therapy in ulcerative colitis.
AffiliationCentre for Colorectal Disease, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland. email@example.com
Anti-Inflammatory Agents, Non-Steroidal
Antibodies, Monoclonal, Humanized
MetadataShow full item record
CitationEfficacy of Adalimumab as a long term maintenance therapy in ulcerative colitis. 2013, 7 (2):150-3 J Crohns Colitis
JournalJournal of Crohn's & colitis
AbstractAdalimumab is a recombinant human IgG1 monoclonal antibody to TNF-alpha. There are limited data with regard to its efficacy in ulcerative colitis. We report experience of adalimumab in ulcerative colitis in a single centre with a focus on the ability of this agent to maintain response and avoid colectomy in the medium to long-term.
- Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome.
- Authors: García-Bosch O, Gisbert JP, Cañas-Ventura A, Merino O, Cabriada JL, García-Sánchez V, Gutiérrez A, Nos P, Peñalva M, Hinojosa J, García-Planella E, Muñoz F, Calvet X, Panés J
- Issue date: 2013 Oct
- Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.
- Authors: Taxonera C, Iglesias E, Muñoz F, Calvo M, Barreiro-de Acosta M, Busquets D, Calvet X, Rodríguez A, Pajares R, Gisbert JP, López-Serrano P, Pérez-Calle JL, Ponferrada Á, De la Coba C, Bermejo F, Chaparro M, Olivares D, Alba C, Fernández-Blanco I
- Issue date: 2017 Feb
- Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab.
- Authors: Taxonera C, Estellés J, Fernández-Blanco I, Merino O, Marín-Jiménez I, Barreiro-de Acosta M, Saro C, García-Sánchez V, Gento E, Bastida G, Gisbert JP, Vera I, Martinez-Montiel P, Garcia-Morán S, Sánchez MC, Mendoza JL
- Issue date: 2011 Feb
- Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
- Authors: Subramaniam K, Richardson A, Dodd J, Platten J, Shadbolt B, Pavli P
- Issue date: 2014 May
- Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience.
- Authors: Oussalah A, Laclotte C, Chevaux JB, Bensenane M, Babouri A, Serre AA, Boucekkine T, Roblin X, Bigard MA, Peyrin-Biroulet L
- Issue date: 2008 Oct 15